ADR120S, Inc. （旧英訳名 Cytori Cell Research Institute,Inc.）
株式会社ＡＤＲ１２０Ｓ
Valuation
Fundamental ratios for the latest reported period.
Ticker: 3750
FY2025 · 2026-03-31
| Gross margin | 20.7% |
| Operating margin | -1777.2% |
| Net margin | -778.4% |
| Return on equity | -1802.1% |
| Return on assets | -107.8% |
| Revenue growth (YoY) | -58.3% |
| EPS (basic) | ¥-44.46 |
| EPS growth (YoY) | — |
| Current ratio | 1.55x |
| Equity ratio | 6.0% |
| Book value / share | ¥2.47 |
| Free cash flow | — |